Cargando…
Management of diabetic dyslipidemia: An update
Diabetic dyslipidemia is a cluster of lipoprotein abnormalities characterized by increased triglyceride level, decreased high-density lipoprotein-cholesterol levels and increase in small dense low-density lipoprotein (LDL) particles. It is extremely common in type 2 diabetes (T2DM) affecting around...
Autores principales: | Jialal, Ishwarlal, Singh, Gurdeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522756/ https://www.ncbi.nlm.nih.gov/pubmed/31139315 http://dx.doi.org/10.4239/wjd.v10.i5.280 |
Ejemplares similares
-
Exploratory metabolomics of metabolic syndrome: A status report
por: Lent-Schochet, Daniella, et al.
Publicado: (2019) -
Management of Hypertriglyceridemia in the Diabetic Patient
por: Jialal, Ishwarlal, et al.
Publicado: (2010) -
Comment on Lopes-Virella et al. Baseline Markers of Inflammation Are Associated With Progression to Macroalbuminuria in Type 1 Diabetic Subjects. Diabetes Care 2013;36:2317–2323
por: Jialal, Ishwarlal, et al.
Publicado: (2014) -
Hyperglycemia Induces Toll-Like Receptor-2 and -4 Expression and Activity in Human Microvascular Retinal Endothelial Cells: Implications for Diabetic Retinopathy
por: Rajamani, Uthra, et al.
Publicado: (2014) -
Erratum to “Hyperglycemia Induces Toll-Like Receptor-2 and -4 Expression and Activity in Human Microvascular Retinal Endothelial Cells: Implications for Diabetic Retinopathy”
por: Rajamani, Uthra, et al.
Publicado: (2016)